m+Medelevator.RU
← Поиск публикаций
Journal of applied toxicology : JAT · 2026

GC-MS Metabolite Profiling and Induction of Cell Death by Sphaeranthus amaranthoides Leaf Extracts.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ramalingam Kaviya, Nagarajan Vishnu, Sekar Niranjni, Selvam Chermakani Panneer, Rajendran Dhinesh Kumar, Chinnasamy Arulvasu, Balakrishnan Kiruthiga, Padmanaban Deepakrajasekar, Sahayanathan Gracy Jenifer

Аннотация

Sphaeranthus amaranthoides, a lesser-known species of the Asteraceae family, has shown promising medicinal properties, prompting investigation into its cytotoxic and pro-apoptotic effects on human cancer cells. This study evaluated aqueous, methanol, ethyl acetate, and hexane leaf extracts for selective anticancer activity. Normal Vero cells and cancer cell lines AGS (gastric) and HT-29 (colorectal) were exposed to Sa-EAE extract, and GC-MS analysis identified key bioactive compounds, including methyl 10,13-dimethyltetradecanoate, 3,7,11,15-tetramethyl-2-hexadecen-1-ol, and 1,3,5-triazine derivatives. The extract showed selective cytotoxicity against AGS cells while sparing normal Vero cells. Apoptosis was evidenced by mitochondrial-membrane depolarization (ΔΨm), cytochrome c release, activation of Caspase-9 and Caspase-3, LDH leakage, and modulation of the Bcl-2/Bax ratio. Apoptotic morphology was confirmed via AO/EB and PI staining. Flow cytometry revealed G0/G1 cell cycle arrest, with downregulation of Cyclin D1 and CDK4 and upregulation of p21 and p27. These findings indicate that Sa-EAE exerts dual effects of mitochondrial-mediated apoptosis and G0/G1 arrest in gastric cancer cells, with minimal toxicity to normal cells, supporting its potential as a therapeutic candidate for further in vivo validation.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты